eXoZymes, Inc. (EXOZ)
NASDAQ: EXOZ · Real-Time Price · USD
7.80
-0.82 (-9.51%)
At close: Jun 9, 2026, 4:00 PM EDT
8.30
+0.50 (6.41%)
After-hours: Jun 9, 2026, 6:48 PM EDT
eXoZymes Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
32
Market Cap
66.14M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 70.07K | 41.47K | 145.01% |
| Dec 31, 2022 | 28.60K | - | - |
| Dec 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionEXOZ News
- 1 day ago - eXoZymes prices 592,270 shares at $18.00 in public offering - TheFly
- 1 day ago - eXoZymes Inc. Announces Pricing of Public Offering of Common Stock and Warrants - Accesswire
- 26 days ago - eXoZymes Quarterly report: Q1 2026 - Filings
- 4 weeks ago - eXoZymes announces graduation from Shell GameChanger Accelerator - TheFly
- 4 weeks ago - eXoZymes Announces Graduation from Shell GameChanger(TM) Accelerator Powered by NLR (GCxN) Program - Accesswire
- 4 weeks ago - eXoZymes Slides: Investor presentation - Filings
- 2 months ago - eXoZymes CCO, Damien Perriman, Outlines NCTx Strategy and the Commercial Path for Cell-Free Biomanufacturing on Grow Everything Podcast - Accesswire
- 2 months ago - eXoZymes Slides: Investor presentation - Filings